Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

In severe eosinophilic asthma controlled with benralizumab, tapering high-dose ICS reduced dose while maintaining control

Matthew B. Stanbrook

ANNALS OF INTERNAL MEDICINE（2024）

Cited 0|Views0
No score
Abstract
Source Citation Jackson DJ, Heaney LG, Humbert M, et al; SHAMAL Investigators. Reduction of daily maintenance inhaled corticosteroids in patients with severe eosinophilic asthma treated with benralizumab (SHAMAL): a randomised, multicentre, open-label, phase 4 study. Lancet. 2024;403:271-281. 38071986 Clinical Impact Ratings GIM/FP/GP: Pulmonology:
More
Translated text
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined